130 research outputs found

    Specialty Fibers for Terahertz Generation and Transmission: A Review

    Get PDF
    Terahertz (THz) frequency range, lying between the optical and microwave frequency ranges covers a significant portion of the electro-magnetic spectrum. Though its initial usage started in the 1960s, active research in the THz field started only in the 1990s by researchers from both optics and microwaves disciplines. The use of optical fibers for THz application has attracted considerable attention in recent years. In this paper, we review the progress and current status of optical fiber-based techniques for THz generation and transmission. The first part of this review focuses on THz sources. After a review on various types of THz sources, we discuss how specialty optical fibers can be used for THz generation. The second part of this review focuses on the guided wave propagation of THz waves for their transmission. After discussing various wave guiding schemes, we consider new fiber designs for THz transmission

    Predicting COVID-19—Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management

    Get PDF
    It is well established that pre-existing comorbid conditions such as hypertension, diabetes, obesity, cardiovascular diseases (CVDs), chronic kidney diseases (CKDs), cancers, and chronic obstructive pulmonary disease (COPD) are associated with increased severity and fatality of COVID-19. The increased death from COVID-19 is due to the unavailability of a gold standard therapeutic and, more importantly, the lack of understanding of how the comorbid conditions and COVID-19 interact at the molecular level, so that personalized management strategies can be adopted. Here, using multi-omics data sets and bioinformatics strategy, we identified the pathway crosstalk between COVID-19 and diabetes, hypertension, CVDs, CKDs, and cancers. Further, shared pathways and hub gene-based targets for COVID-19 and its associated specific and combination of comorbid conditions are also predicted towards developing personalized management strategies. The approved drugs for most of these identified targets are also provided towards drug repurposing. Literature supports the involvement of our identified shared pathways in pathogenesis of COVID-19 and development of the specific comorbid condition of interest. Similarly, shared pathways- and hub gene-based targets are also found to have potential implementations in managing COVID-19 patients. However, the identified targets and drugs need further careful evaluation for their repurposing towards personalized treatment of COVID-19 cases having pre-existing specific comorbid conditions we have considered in this analysis. The method applied here may also be helpful in identifying common pathway components and targets in other disease-disease interactions too
    corecore